![](https://investorshub.advfn.com/uicon/35140.png?cb=1569367903)
Tuesday, July 09, 2013 9:02:38 AM
"The recent roll out of our flagship product is a milestone for the company and we expect to move quickly towards a second production run. Our team is working on finalizing the details of our endorsement deal with Jay Cutler and furthermore we anticipate closing similar deals with top athletes in other professional sports. Our group has outlined a broad media strategy that will kick off once we close our initial deal with Jay Cutler," said Bill Gallagher, president and CEO at Bio-Solutions Corp.
Management is committed to maximizing the long term branding potential for Type 2 Defense and we fully expect that we will be successful in creating sustained value for shareholders on both a short and long term basis. Shareholders can expect prolonged news flow from the company in a timely fashion.
Consumers can find more information about the product by going to www.BioSolutionsCorp.com/product.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements which address actual results could differ materially from those expressed or implied in forward-looking statements. These statements are made on the basis of management's views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as management "believes", "expects", "anticipates", "foresees", "forecasts", "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that the ability to attract clients and generate business may be affected by a decline in the Company's financial ratings, the competitive environment, the Company's ability to raise sufficient capital to meet the collateral requirements associated with its current business and to fund the Company's continuing operations and changes in market conditions.
FOR FURTHER INFORMATION PLEASE CONTACT: Bio-Solutions Corp. William Gallagher Chief Executive Officer 210-373-8104
Bio-Solutions Corp. Josh Williams Endorsement Deal Coordinator 312-636-1471 joshwilliams0626@yahoo.com www.BioSolutionsCorp.com
SOURCE: Bio-Solutions Corp.
? 2013 Marketwire L.P. All rights reserved.
Recent GLUC News
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 12/07/2023 07:58:40 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 06/28/2023 05:23:12 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM